Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Nontuberculous Mycobacteria in Portugal: Trends from the last decade
A. Santos; S. Carneiro; A. Silva; J.P. Gomes; R. Macedo;
Pulmonol. 2024;30:337-43
Improving non-small-cell lung cancer survival through molecular characterization: Perspective of a multidisciplinary expert panel
M.G.O. Fernandes; A.S. Vilariça; B. Fernandes; C. Camacho; C. Saraiva; F. Estevinho; H. Novais e Bastos; J.M. Lopes; P. Fidalgo; P. Garrido; S. Alves; S. Silva; T. Sequeira; F. Barata;
Pulmonol. 2024;30:4-7
Impact of systemic inflammatory markers in patients with ALK-positive non-small cell lung cancer treated with crizotinib
O.F. Olmez; A. Bilici; P. Gursoy; E. Cubukcu; A. Sakin; T. Korkmaz; I. Cil; B. Cakar; S. Menekse; T. Demir; O. Acikgoz; J. Hamdard;
Pulmonol. 2023;29:478-85